Abstract:The final, formatted version of the article will be published soon. You have multiple emails registered with Frontiers: Please enter your email address: If you already have an account, please login You don't have a Frontiers account ? You can register here Introduction: Antimicrobial-resistant pathogens are an ongoing threat to human and animal health.Colistin is considered the last resort antibiotic against human infections due to multidrug-resistant Gram-negative organisms, including Acinetobacter baumanni, a priority 1 pathogen according to the WHO. Despite colistin being a last resort, transferable bacterial resistance to this drug has been reported in humans and animals, making the need to tackle colistin resistance an essential path. The large PetN transferase membrane protein PmrC is the main responsible for colistin resistance, due to its catalysed modification of lipid A of the external membrane. Despite its importance, this potential drug target was never characterised at a molecular level.Methods: Recombinant production of large membrane proteins in their native forms is a bottleneck in modern molecular biology. We recombinantly produced PmrC and biophysically characterised it in solution. We employed in silico approaches, including virtual screening and molecular modelling, to identify PmrC ligands. Binding of these ligands to PmrC was measured using Microscale thermophoresis (MST). The best ligand was tested to its ability to hamper colistin resistance in A. baumannii clinical isolates. Finally, we checked that the identified compound is not cytotoxic at the used concentrations by haemolysis assays.We successfully produced PmrC PetN transferase membrane protein in high yields and showed that PmrC is a stable - protein, with melting temperature Tm=60°C. Based on PmrC structural model, we identified a promising druggable cavity. Therefore, we used a structure based virtual screening to identify potential inhibitors. A small molecule, here denominated as s-Phen, was proved to bind PmrC with μM affinity. Microbiological assays confirmed that the s-Phen can drastically reduce colistin MIC in two A. baumannii resistant isolates and that it is not cytotoxic.Importantly, PmrC binding pocket to s-Phen is highly conserved in all homologs of PmrC, regardless of the location of genes encoding for them and of their operons.Discussion: Our study provides a molecular characterisation of PmrC and demonstrates the importance of PmrC as a drug target and the strong potential of PmrC binding molecules to act as colistin adjuvants, operating as synergistic tools to combat multi-resistant nocosomial pathogens.

Phage-mediated colistin resistance in Acinetobacter baumannii

The Effect of Colistin Resistance-Associated Mutations on the Fitness of Acinetobacter Baumannii

In Vivo Emergence Of Colistin Resistance In Carbapenem-Resistant Klebsiella Pneumoniae Mediated By Premature Termination Of The Mgrb Gene Regulator

Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates

Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology

New Mutations Involved in Colistin Resistance in Acinetobacter Baumannii

Colistin Resistance in Acinetobacter Baumannii MDR-ZJ06 Revealed by a Multiomics Approach

Molecular mechanisms of colistin resistance mediated by pmrCAB genes in Acinetobacter baumannii isolated from patients hospitalized in Isfahan medical centers

Alteration in the Morphological and Transcriptomic Profiles of Acinetobacter baumannii after Exposure to Colistin

Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates

The Co-Transfer of Plasmid-Borne Colistin-Resistant Genes Mcr-1 and Mcr-3.5, the Carbapenemase Gene Blandm-5 and the 16S Methylase Gene Rmtb from Escherichia Coli

Silent Transmission of an IS 1294b -Deactivated Mcr-1 Gene with Inducible Colistin Resistance

Structure-based targeting of the lipid A-modifying enzyme PmrC to contrast colistin resistance in Acinetobacter baumannii

Retained colistin susceptibility in clinical Acinetobacter baumannii isolates with multiple mutations in pmrCAB and lpxACD operons

Whole-genome sequencing for the characterization of resistance mechanisms and epidemiology of colistin-resistant Acinetobacter baumannii

Genetic and structural basis of colistin resistance in Klebsiella pneumoniae: Unravelling the molecular mechanisms

Whole-Genome Sequencing of a Colistin-Resistant Acinetobacter baumannii Strain Isolated at a Tertiary Health Facility in Pretoria, South Africa

Deciphering MCR-2 Colistin Resistance.

A Systematic Review and Meta-Analysis of Molecular Characteristics on Colistin Resistance of Acinetobacter baumannii

Current Update on Intrinsic and Acquired Colistin Resistance Mechanisms in Bacteria

Outer membrane permeability of mcr-positive bacteria reveals potent synergy of colistin and macromolecular antibiotics against colistin-resistant Acinetobacter baumannii